Digitalisation stands to radically improve the highly bureaucratic healthcare system to create something faster and more flexible
In Conversation
The Greek authorities should try to find a balance which provides drugs to a wider segment of the population but does not put the entire bill…
The way our system has developed means that either we all win together, or we all lose together. Collaboration, therefore, is the key to future success
To further uplift [Greece's] positioning [as a clinical trials hub], administrative procedures should be decomplexified to create a more promising environment for collaboration among stakeholders
We believe that evolution can come through fostering ecosystems in the sector since the challenges are often multi-factorial
Greece is the second and third largest patient enroller globally for two of GSK’s clinical trials in lung cancer and multiple myeloma respectively, drawing on the…
EU Recovery and Resilience Funding (RRF) is coming online, creating an opportunity for Greece to improve its healthcare system, which we are fully aligned with and…
The Greek healthcare system is in the initial stages of an important restructuring and reform, and there will be many opportunities going forward
It is a point of national pride to be able to assist Greek firms to enter prestigious international markets
Due to the 2008 crisis and its effects on the [Greek] pharmaceutical market, the company has given an increased focus to exports over the last few…
My team and I are constantly focused on understanding needs throughout the entire patient journey, identifying where areas for improvement exist, and how we can keep…
It is now once more an attractive proposition to invest in Greek manufacturing and regain some of the momentum lost in the previous decade
